Tracking Unscheduled Treatment: What Your Report Misses

Unscheduled treatment is diagnosed, presented treatment that has not been scheduled or completed. Your practice management system will hand you that number on demand, but it counts dollars, not decisions, so a patient who declined, a patient who is still thinking, and a consult where nobody wrote anything down all land in the same column. That makes the report a starting point for investigation, not a verdict on your case acceptance.

Most practices skip straight from the number to the follow-up campaign. That is the expensive mistake. If the biggest slice of your unscheduled list is not people who said no, a recall blast aimed at people who said no will underperform no matter how good the message is. Clean the list before you work the list.

What is unscheduled treatment, and what does the report actually count?

Every major practice management system produces some version of this report. It pulls treatment that was diagnosed and entered into the ledger, then filters out anything with a completed procedure code or a future appointment attached. Whatever is left shows up as unscheduled, usually as a dollar total.

Notice what that logic captures. It captures the absence of an appointment. It does not capture the patient's actual answer, because in most systems there is no field for the answer and no requirement that anyone record one.

So the report measures a gap in your schedule, and you are the one inferring a gap in your closing. Those are different things, and the difference is where the money hides.

Why is the unscheduled number unreliable in most practices?

Because a large share of consults never produce a recorded outcome at all.

DentScribe, a dental software vendor, announced a white paper on August 31, 2026 that analyzed treatment coordinator conversations and what happened after them. Its headline finding was that 46 percent of visits in the sample ended with no appointment recorded. The same paper reported that 98 office commitments were made without an owner or a due date attached, and that 65,696 dollars of quoted treatment sat unresolved in the sample.

Two caveats before you carry that number anywhere. It is a vendor white paper, not peer-reviewed research, and the company did not disclose the sample size or the methodology behind it. Treat it as a directional signal about how consults get documented, not as an industry benchmark.

Even as a directional signal, it explains something practices feel every month. When nothing gets recorded, silence gets filed as a no, and a no gets filed as a lost case. The ledger cannot tell the difference between a patient who rejected the plan and a patient who walked out of a conversation that simply never reached a decision point.

The benchmark that is not really a benchmark

You have probably seen the claim that 40 to 60 percent of diagnosed treatment never gets scheduled. It appears in vendor blogs, conference decks, and consultant newsletters, almost always without a citation. We went looking for the primary study behind it and could not find one.

That is worth sitting with, because it means the industry has been comparing itself to a number nobody measured. If the external benchmark is unsourced and your own report is noisy, the only honest comparison left is your own trend line, measured consistently month over month.

How should a practice split the unscheduled list?

One list treated as one problem produces one generic response. Split it into three buckets instead, because only one of the three is actually a follow-up problem.

• No recorded outcome. The consult happened, the plan was presented, and nothing in the record says what the patient decided. This is usually the largest bucket, and it is a documentation problem, not a persuasion problem.
• A real deferral with a stated reason. The patient said not now, and somebody captured why. Budget, timing, a spouse to consult, a procedure they want done first. This bucket is where follow-up actually earns its keep, because you know what to address.
• A hard decline. The patient considered the plan and said no. Respect it, log it, and stop spending outreach on it.

The framework matters more than the tooling. If your system has no place to record which bucket a case belongs to, fix that first, ahead of any outreach sequence. A practice that can sort its list will out-collect a practice that can only blast it.

What makes a consult end with a recorded outcome?

The DentScribe paper is more useful here than in the headline. It scored conversations against five case-acceptance essentials: reviewing the plan, discussing financials, presenting payment options, scheduling, and confirming next steps. Conversations that covered all five booked at 62 percent. Conversations that covered three or fewer booked at 10 percent, a 6.2 times gap between complete and incomplete conversations.

The two elements most often missing were both about money. In that sample, 36 percent of conversations never mentioned a way to pay, and only 21 percent gave the patient their own out-of-pocket figure.

That is the whole mechanism in one line. A patient cannot say yes to a number they were never given, and a coordinator cannot record an outcome to a question that was never asked. The consult ends politely, the patient leaves, and the ledger quietly files an ambiguity as a loss.

Here is what different consult endings actually leave behind:

What the consult produced	What gets recorded	The follow-up list a month later	What the practice can measure
A verbal yes, no record	Nothing beyond the diagnosis	Patient looks identical to a decline	Nothing. The case is invisible until it ages out
A written estimate handed over at the desk	A quoted dollar figure, no response	A large pile of maybes with no reason attached	Total dollars quoted, and nothing about intent
A priced plan the patient saw and responded to chairside	Plan, price, and the patient's actual answer	A short list of real deferrals with stated reasons	Outcome rate, decision time, and recovery rate by reason

Only the third row produces a list worth working. The first two produce a number worth worrying about.

Where does visualization change the measurement?

Elective cosmetic treatment has no clinical urgency to fall back on. A cracked molar creates its own deadline. Veneers do not, so a vague ending is the default unless something in the visit brings the decision forward while the patient is still present.

That is the specific problem Smile PreVue solves. It renders a photorealistic simulation of the patient's cosmetic result in about 30 seconds, chairside on an iPad, with no additional hardware, so the patient reacts to their own outcome during the visit instead of imagining it in the parking lot. Because the treatment plan can be priced and paid for on the same device, with pay-in-full or pay-over-time options through third-party providers subject to their approval, the visit tends to produce a recorded answer rather than an open question. The platform is HIPAA-compliant and covered by a BAA.

The contrast with Digital Smile Design is instructive here, and it is not a knock on the protocol. DSD is a planning methodology that happens between visits, which is exactly right for complex full-mouth rehabilitation. But moving the visualization out of the operatory also moves the decision out of the operatory, and a decision made somewhere else is a decision your ledger cannot see. For a single-visit cosmetic consult, keeping the moment inside the room is what keeps the outcome recordable.

This is one piece of a larger dental sales process, and no tool fixes a consult that never discusses money. But it removes the most common reason a cosmetic conversation ends without an answer, which is a patient who cannot picture what they are buying.

What should a practice measure instead of one big number?

Retire the single dollar figure as your primary metric. Track three things instead.

Share of consults with a recorded outcome. Of the case presentations you did last month, what percentage have a documented patient response? This is your leading indicator. It moves first, you control it directly, and it is a pure documentation discipline before it is anything else.

Time from presentation to decision. Measure the days between the plan being presented and an outcome being recorded. As this shrinks, your recorded-outcome rate rises, because decisions made in the chair get logged and decisions deferred indefinitely do not.

Recovery rate on the deferral bucket only. How many stated-reason deferrals eventually schedule? This is the only number that honestly grades your follow-up, because it is the only bucket where follow-up is the right intervention. Measuring recovery against the whole list will always look terrible and will never tell you why.

Acceptance rate is still worth reporting, but understand that it is the lagging indicator. It summarizes a quarter of consult behavior after the fact. The recorded-outcome rate tells you what is happening this week, while you can still do something about it.

FAQ

What counts as unscheduled treatment? Treatment that has been diagnosed and presented to the patient but has neither been completed nor scheduled for a future appointment. It is a ledger status, not a patient decision.

How much diagnosed treatment goes unscheduled in a typical practice? Nobody credibly knows. The frequently repeated 40 to 60 percent range has no primary study behind it, so treat your own consistently measured trend line as the only benchmark worth managing against.

Why is my unscheduled treatment report so large? Usually because it includes every consult that ended without a documented answer, not just patients who declined. It also tends to accumulate old diagnoses that were never formally closed out or re-presented.

How often should a practice review unscheduled treatment? Review the composition monthly, sorted into the three buckets, and watch the recorded-outcome rate weekly. Reviewing only the dollar total will not tell you what changed.

Does showing a patient the result help close the case in the same visit? For elective cosmetic treatment, seeing the outcome removes the guesswork that drives most deferrals. A patient who can see the result and the price in the same visit is far more likely to give an answer you can actually record.

Start with a cleaner number

The practices that grow cosmetic revenue are rarely the ones with the best follow-up sequence. They are the ones whose consults end with an answer, so the follow-up list is short, honest, and worth the phone call.

If your cosmetic consults keep ending in ambiguity, see what changes when the patient can see the result before they leave the chair. Start a 3-day free trial of Smile PreVue through the App Store and run it on your next cosmetic case.